id	sid	tid	token	lemma	pos
cord-279485-hajrnur1	1	1	key	key	JJ
cord-279485-hajrnur1	1	2	:	:	:
cord-279485-hajrnur1	1	3	cord-279485-hajrnur1	cord-279485-hajrnur1	JJ
cord-279485-hajrnur1	1	4	authors	author	NNS
cord-279485-hajrnur1	1	5	:	:	:
cord-279485-hajrnur1	1	6	Pope	Pope	NNP
cord-279485-hajrnur1	1	7	,	,	,
cord-279485-hajrnur1	2	1	Janet	Janet	NNP
cord-279485-hajrnur1	2	2	E.	E.	NNP
cord-279485-hajrnur1	2	3	title	title	NN
cord-279485-hajrnur1	2	4	:	:	:
cord-279485-hajrnur1	3	1	What	what	WP
cord-279485-hajrnur1	3	2	Does	do	VBZ
cord-279485-hajrnur1	3	3	the	the	DT
cord-279485-hajrnur1	3	4	COVID-19	COVID-19	NNP
cord-279485-hajrnur1	3	5	Pandemic	Pandemic	NNP
cord-279485-hajrnur1	3	6	Mean	Mean	NNP
cord-279485-hajrnur1	3	7	for	for	IN
cord-279485-hajrnur1	3	8	Rheumatology	Rheumatology	NNP
cord-279485-hajrnur1	3	9	Patients	patient	NNS
cord-279485-hajrnur1	3	10	?	?	.
cord-279485-hajrnur1	4	1	date	date	NN
cord-279485-hajrnur1	4	2	:	:	:
cord-279485-hajrnur1	4	3	2020	2020	CD
cord-279485-hajrnur1	4	4	-	-	HYPH
cord-279485-hajrnur1	4	5	04	04	CD
cord-279485-hajrnur1	4	6	-	-	SYM
cord-279485-hajrnur1	4	7	30	30	CD
cord-279485-hajrnur1	4	8	journal	journal	NN
cord-279485-hajrnur1	4	9	:	:	:
cord-279485-hajrnur1	5	1	Curr	Curr	NNP
cord-279485-hajrnur1	5	2	Treatm	Treatm	NNP
cord-279485-hajrnur1	6	1	Opt	Opt	NNP
cord-279485-hajrnur1	6	2	Rheumatol	Rheumatol	NNP
cord-279485-hajrnur1	6	3	DOI	DOI	NNP
cord-279485-hajrnur1	6	4	:	:	:
cord-279485-hajrnur1	7	1	10.1007	10.1007	CD
cord-279485-hajrnur1	7	2	/	/	SYM
cord-279485-hajrnur1	7	3	s40674	s40674	CD
cord-279485-hajrnur1	7	4	-	-	HYPH
cord-279485-hajrnur1	7	5	020	020	CD
cord-279485-hajrnur1	7	6	-	-	HYPH
cord-279485-hajrnur1	7	7	00145-y	00145-y	XX
cord-279485-hajrnur1	8	1	sha	sha	NNP
cord-279485-hajrnur1	8	2	:	:	:
cord-279485-hajrnur1	9	1	19bc9c316614e8057f6c917116671f5d05452ed5	19bc9c316614e8057f6c917116671f5d05452ed5	CD
cord-279485-hajrnur1	9	2	doc_id	doc_id	CD
cord-279485-hajrnur1	9	3	:	:	:
cord-279485-hajrnur1	10	1	279485	279485	CD
cord-279485-hajrnur1	10	2	cord_uid	cord_uid	NNS
cord-279485-hajrnur1	10	3	:	:	:
cord-279485-hajrnur1	10	4	hajrnur1	hajrnur1	JJ
cord-279485-hajrnur1	10	5	PURPOSE	purpose	NN
cord-279485-hajrnur1	10	6	OF	of	IN
cord-279485-hajrnur1	10	7	REVIEW	review	NN
cord-279485-hajrnur1	10	8	:	:	:
cord-279485-hajrnur1	11	1	The	the	DT
cord-279485-hajrnur1	11	2	COVID-19	covid-19	JJ
cord-279485-hajrnur1	11	3	outbreak	outbreak	NN
cord-279485-hajrnur1	11	4	has	have	VBZ
cord-279485-hajrnur1	11	5	resulted	result	VBN
cord-279485-hajrnur1	11	6	in	in	IN
cord-279485-hajrnur1	11	7	uncertainty	uncertainty	NN
cord-279485-hajrnur1	11	8	for	for	IN
cord-279485-hajrnur1	11	9	patients	patient	NNS
cord-279485-hajrnur1	11	10	with	with	IN
cord-279485-hajrnur1	11	11	autoimmune	autoimmune	JJ
cord-279485-hajrnur1	11	12	rheumatic	rheumatic	JJ
cord-279485-hajrnur1	11	13	diseases	disease	NNS
cord-279485-hajrnur1	11	14	for	for	IN
cord-279485-hajrnur1	11	15	several	several	JJ
cord-279485-hajrnur1	11	16	reasons	reason	NNS
cord-279485-hajrnur1	11	17	.	.	.
cord-279485-hajrnur1	12	1	They	-PRON-	PRP
cord-279485-hajrnur1	12	2	are	be	VBP
cord-279485-hajrnur1	12	3	concerned	concerned	JJ
cord-279485-hajrnur1	12	4	about	about	IN
cord-279485-hajrnur1	12	5	their	-PRON-	PRP$
cord-279485-hajrnur1	12	6	risk	risk	NN
cord-279485-hajrnur1	12	7	of	of	IN
cord-279485-hajrnur1	12	8	developing	develop	VBG
cord-279485-hajrnur1	12	9	COVID-19	COVID-19	.
cord-279485-hajrnur1	13	1	as	as	IN
cord-279485-hajrnur1	13	2	many	many	JJ
cord-279485-hajrnur1	13	3	are	be	VBP
cord-279485-hajrnur1	13	4	immune	immune	JJ
cord-279485-hajrnur1	13	5	suppressed	suppress	VBN
cord-279485-hajrnur1	13	6	from	from	IN
cord-279485-hajrnur1	13	7	their	-PRON-	PRP$
cord-279485-hajrnur1	13	8	disease	disease	NN
cord-279485-hajrnur1	13	9	and/or	and/or	CC
cord-279485-hajrnur1	13	10	treatment	treatment	NN
cord-279485-hajrnur1	13	11	,	,	,
cord-279485-hajrnur1	13	12	whether	whether	IN
cord-279485-hajrnur1	13	13	they	-PRON-	PRP
cord-279485-hajrnur1	13	14	should	should	MD
cord-279485-hajrnur1	13	15	stop	stop	VB
cord-279485-hajrnur1	13	16	their	-PRON-	PRP$
cord-279485-hajrnur1	13	17	advanced	advanced	JJ
cord-279485-hajrnur1	13	18	therapies	therapy	NNS
cord-279485-hajrnur1	13	19	,	,	,
cord-279485-hajrnur1	13	20	if	if	IN
cord-279485-hajrnur1	13	21	they	-PRON-	PRP
cord-279485-hajrnur1	13	22	will	will	MD
cord-279485-hajrnur1	13	23	have	have	VB
cord-279485-hajrnur1	13	24	a	a	DT
cord-279485-hajrnur1	13	25	worse	bad	JJR
cord-279485-hajrnur1	13	26	outcome	outcome	NN
cord-279485-hajrnur1	13	27	if	if	IN
cord-279485-hajrnur1	13	28	/	/	SYM
cord-279485-hajrnur1	13	29	when	when	WRB
cord-279485-hajrnur1	13	30	infected	infect	VBN
cord-279485-hajrnur1	13	31	due	due	IN
cord-279485-hajrnur1	13	32	to	to	IN
cord-279485-hajrnur1	13	33	their	-PRON-	PRP$
cord-279485-hajrnur1	13	34	underlying	underlying	JJ
cord-279485-hajrnur1	13	35	medication	medication	NN
cord-279485-hajrnur1	13	36	condition(s	condition(s	NN
cord-279485-hajrnur1	13	37	)	)	-RRB-
cord-279485-hajrnur1	14	1	and	and	CC
cord-279485-hajrnur1	14	2	if	if	IN
cord-279485-hajrnur1	14	3	they	-PRON-	PRP
cord-279485-hajrnur1	14	4	will	will	MD
cord-279485-hajrnur1	14	5	have	have	VB
cord-279485-hajrnur1	14	6	drug	drug	NN
cord-279485-hajrnur1	14	7	availability	availability	NN
cord-279485-hajrnur1	14	8	,	,	,
cord-279485-hajrnur1	14	9	especially	especially	RB
cord-279485-hajrnur1	14	10	with	with	IN
cord-279485-hajrnur1	14	11	press	press	NN
cord-279485-hajrnur1	14	12	(	(	-LRB-
cord-279485-hajrnur1	14	13	without	without	IN
cord-279485-hajrnur1	14	14	much	much	JJ
cord-279485-hajrnur1	14	15	data	datum	NNS
cord-279485-hajrnur1	14	16	)	)	-RRB-
cord-279485-hajrnur1	14	17	coverage	coverage	NN
cord-279485-hajrnur1	14	18	suggesting	suggest	VBG
cord-279485-hajrnur1	14	19	hydroxychloroquine	hydroxychloroquine	NNP
cord-279485-hajrnur1	14	20	may	may	MD
cord-279485-hajrnur1	14	21	be	be	VB
cord-279485-hajrnur1	14	22	used	use	VBN
cord-279485-hajrnur1	14	23	in	in	IN
cord-279485-hajrnur1	14	24	COVID-19	covid-19	DT
cord-279485-hajrnur1	14	25	infection	infection	NN
cord-279485-hajrnur1	14	26	causing	cause	VBG
cord-279485-hajrnur1	14	27	diversion	diversion	NN
cord-279485-hajrnur1	14	28	of	of	IN
cord-279485-hajrnur1	14	29	medication	medication	NN
cord-279485-hajrnur1	14	30	supply	supply	NN
cord-279485-hajrnur1	14	31	.	.	.
cord-279485-hajrnur1	15	1	This	this	DT
cord-279485-hajrnur1	15	2	article	article	NN
cord-279485-hajrnur1	15	3	discusses	discuss	VBZ
cord-279485-hajrnur1	15	4	how	how	WRB
cord-279485-hajrnur1	15	5	the	the	DT
cord-279485-hajrnur1	15	6	pandemic	pandemic	NN
cord-279485-hajrnur1	15	7	affects	affect	VBZ
cord-279485-hajrnur1	15	8	people	people	NNS
cord-279485-hajrnur1	15	9	with	with	IN
cord-279485-hajrnur1	15	10	systemic	systemic	JJ
cord-279485-hajrnur1	15	11	autoimmune	autoimmune	JJ
cord-279485-hajrnur1	15	12	rheumatic	rheumatic	JJ
cord-279485-hajrnur1	15	13	diseases	disease	NNS
cord-279485-hajrnur1	15	14	.	.	.
cord-279485-hajrnur1	16	1	RECENT	recent	JJ
cord-279485-hajrnur1	16	2	FINDINGS	finding	NNS
cord-279485-hajrnur1	16	3	:	:	:
cord-279485-hajrnur1	17	1	Preliminarily	preliminarily	RB
cord-279485-hajrnur1	17	2	,	,	,
cord-279485-hajrnur1	17	3	articles	article	NNS
cord-279485-hajrnur1	17	4	seem	seem	VBP
cord-279485-hajrnur1	17	5	to	to	TO
cord-279485-hajrnur1	17	6	suggest	suggest	VB
cord-279485-hajrnur1	17	7	that	that	IN
cord-279485-hajrnur1	17	8	patients	patient	NNS
cord-279485-hajrnur1	17	9	with	with	IN
cord-279485-hajrnur1	17	10	rheumatic	rheumatic	JJ
cord-279485-hajrnur1	17	11	diseases	disease	NNS
cord-279485-hajrnur1	17	12	may	may	MD
cord-279485-hajrnur1	17	13	not	not	RB
cord-279485-hajrnur1	17	14	have	have	VB
cord-279485-hajrnur1	17	15	more	more	JJR
cord-279485-hajrnur1	17	16	infections	infection	NNS
cord-279485-hajrnur1	17	17	from	from	IN
cord-279485-hajrnur1	17	18	SARS	SARS	NNP
cord-279485-hajrnur1	17	19	-	-	HYPH
cord-279485-hajrnur1	17	20	CoV-2	CoV-2	NNP
cord-279485-hajrnur1	17	21	and	and	CC
cord-279485-hajrnur1	17	22	similar	similar	JJ
cord-279485-hajrnur1	17	23	outcomes	outcome	NNS
cord-279485-hajrnur1	17	24	to	to	IN
cord-279485-hajrnur1	17	25	age	age	NN
cord-279485-hajrnur1	17	26	and	and	CC
cord-279485-hajrnur1	17	27	gender	gender	NN
cord-279485-hajrnur1	17	28	matched	match	VBN
cord-279485-hajrnur1	17	29	patients	patient	NNS
cord-279485-hajrnur1	17	30	,	,	,
cord-279485-hajrnur1	17	31	but	but	CC
cord-279485-hajrnur1	17	32	fear	fear	NN
cord-279485-hajrnur1	17	33	of	of	IN
cord-279485-hajrnur1	17	34	rheumatic	rheumatic	JJ
cord-279485-hajrnur1	17	35	medications	medication	NNS
cord-279485-hajrnur1	17	36	increasing	increase	VBG
cord-279485-hajrnur1	17	37	their	-PRON-	PRP$
cord-279485-hajrnur1	17	38	risk	risk	NN
cord-279485-hajrnur1	17	39	,	,	,
cord-279485-hajrnur1	17	40	drug	drug	NN
cord-279485-hajrnur1	17	41	shortages	shortage	NNS
cord-279485-hajrnur1	17	42	,	,	,
cord-279485-hajrnur1	17	43	and	and	CC
cord-279485-hajrnur1	17	44	work	work	VB
cord-279485-hajrnur1	17	45	exposure	exposure	NN
cord-279485-hajrnur1	17	46	all	all	DT
cord-279485-hajrnur1	17	47	are	be	VBP
cord-279485-hajrnur1	17	48	concerns	concern	NNS
cord-279485-hajrnur1	17	49	for	for	IN
cord-279485-hajrnur1	17	50	patients	patient	NNS
cord-279485-hajrnur1	17	51	.	.	.
cord-279485-hajrnur1	18	1	RECENT	recent	JJ
cord-279485-hajrnur1	18	2	FINDINGS	finding	NNS
cord-279485-hajrnur1	18	3	:	:	:
cord-279485-hajrnur1	19	1	The	the	DT
cord-279485-hajrnur1	19	2	long	long	JJ
cord-279485-hajrnur1	19	3	term	term	NN
cord-279485-hajrnur1	19	4	effects	effect	NNS
cord-279485-hajrnur1	19	5	of	of	IN
cord-279485-hajrnur1	19	6	the	the	DT
cord-279485-hajrnur1	19	7	pandemic	pandemic	NN
cord-279485-hajrnur1	19	8	in	in	IN
cord-279485-hajrnur1	19	9	patients	patient	NNS
cord-279485-hajrnur1	19	10	with	with	IN
cord-279485-hajrnur1	19	11	rheumatic	rheumatic	JJ
cord-279485-hajrnur1	19	12	diseases	disease	NNS
cord-279485-hajrnur1	19	13	will	will	MD
cord-279485-hajrnur1	19	14	not	not	RB
cord-279485-hajrnur1	19	15	be	be	VB
cord-279485-hajrnur1	19	16	known	know	VBN
cord-279485-hajrnur1	19	17	until	until	IN
cord-279485-hajrnur1	19	18	much	much	RB
cord-279485-hajrnur1	19	19	later	later	RB
cord-279485-hajrnur1	19	20	and	and	CC
cord-279485-hajrnur1	19	21	likely	likely	RB
cord-279485-hajrnur1	19	22	include	include	VBP
cord-279485-hajrnur1	19	23	stressors	stressor	NNS
cord-279485-hajrnur1	19	24	flaring	flare	VBG
cord-279485-hajrnur1	19	25	disease	disease	NN
cord-279485-hajrnur1	19	26	(	(	-LRB-
cord-279485-hajrnur1	19	27	fear	fear	NN
cord-279485-hajrnur1	19	28	,	,	,
cord-279485-hajrnur1	19	29	illness	illness	NN
cord-279485-hajrnur1	19	30	,	,	,
cord-279485-hajrnur1	19	31	job	job	NN
cord-279485-hajrnur1	19	32	loss	loss	NN
cord-279485-hajrnur1	19	33	,	,	,
cord-279485-hajrnur1	19	34	social	social	JJ
cord-279485-hajrnur1	19	35	isolation	isolation	NN
cord-279485-hajrnur1	19	36	)	)	-RRB-
cord-279485-hajrnur1	19	37	,	,	,
cord-279485-hajrnur1	19	38	post	post	JJ
cord-279485-hajrnur1	19	39	-	-	JJ
cord-279485-hajrnur1	19	40	traumatic	traumatic	JJ
cord-279485-hajrnur1	19	41	stress	stress	NN
cord-279485-hajrnur1	19	42	,	,	,
cord-279485-hajrnur1	19	43	flaring	flare	VBG
cord-279485-hajrnur1	19	44	due	due	IN
cord-279485-hajrnur1	19	45	to	to	IN
cord-279485-hajrnur1	19	46	stopping	stop	VBG
cord-279485-hajrnur1	19	47	medications	medication	NNS
cord-279485-hajrnur1	19	48	,	,	,
cord-279485-hajrnur1	19	49	less	less	JJR
cord-279485-hajrnur1	19	50	physician	physician	NN
cord-279485-hajrnur1	19	51	visits	visit	NNS
cord-279485-hajrnur1	19	52	with	with	IN
cord-279485-hajrnur1	19	53	subsequent	subsequent	JJ
cord-279485-hajrnur1	19	54	under	under	IN
cord-279485-hajrnur1	19	55	-	-	HYPH
cord-279485-hajrnur1	19	56	treatment	treatment	NN
cord-279485-hajrnur1	19	57	,	,	,
cord-279485-hajrnur1	19	58	and	and	CC
cord-279485-hajrnur1	19	59	increases	increase	NNS
cord-279485-hajrnur1	19	60	in	in	IN
cord-279485-hajrnur1	19	61	chronic	chronic	JJ
cord-279485-hajrnur1	19	62	concomitant	concomitant	JJ
cord-279485-hajrnur1	19	63	fatigue	fatigue	NN
cord-279485-hajrnur1	19	64	,	,	,
cord-279485-hajrnur1	19	65	pain	pain	NN
cord-279485-hajrnur1	19	66	,	,	,
cord-279485-hajrnur1	19	67	fibromyalgia	fibromyalgia	NN
cord-279485-hajrnur1	19	68	.	.	.
cord-279485-hajrnur1	20	1	The	the	DT
cord-279485-hajrnur1	20	2	COVID-19	covid-19	CD
cord-279485-hajrnur1	20	3	pandemic	pandemic	NN
cord-279485-hajrnur1	20	4	may	may	MD
cord-279485-hajrnur1	20	5	be	be	VB
cord-279485-hajrnur1	20	6	considered	consider	VBN
cord-279485-hajrnur1	20	7	'	'	''
cord-279485-hajrnur1	20	8	the	the	DT
cord-279485-hajrnur1	20	9	cough	cough	NN
cord-279485-hajrnur1	20	10	that	that	WDT
cord-279485-hajrnur1	20	11	changed	change	VBD
cord-279485-hajrnur1	20	12	the	the	DT
cord-279485-hajrnur1	20	13	world	world	NN
cord-279485-hajrnur1	20	14	.	.	.
cord-279485-hajrnur1	20	15	'	'	''
cord-279485-hajrnur1	21	1	On	on	IN
cord-279485-hajrnur1	21	2	March	March	NNP
cord-279485-hajrnur1	21	3	11	11	CD
cord-279485-hajrnur1	21	4	,	,	,
cord-279485-hajrnur1	21	5	2020	2020	CD
cord-279485-hajrnur1	21	6	,	,	,
cord-279485-hajrnur1	21	7	the	the	DT
cord-279485-hajrnur1	21	8	World	World	NNP
cord-279485-hajrnur1	21	9	Health	Health	NNP
cord-279485-hajrnur1	21	10	Organization	Organization	NNP
cord-279485-hajrnur1	21	11	declared	declare	VBD
cord-279485-hajrnur1	21	12	the	the	DT
cord-279485-hajrnur1	21	13	COVID-19	COVID-19	NNP
cord-279485-hajrnur1	21	14	virus	virus	NN
cord-279485-hajrnur1	21	15	a	a	DT
cord-279485-hajrnur1	21	16	pandemic	pandemic	NN
cord-279485-hajrnur1	21	17	[	[	-LRB-
cord-279485-hajrnur1	21	18	1	1	CD
cord-279485-hajrnur1	21	19	]	]	-RRB-
cord-279485-hajrnur1	21	20	which	which	WDT
cord-279485-hajrnur1	21	21	is	be	VBZ
cord-279485-hajrnur1	21	22	extremely	extremely	RB
cord-279485-hajrnur1	21	23	fast	fast	JJ
cord-279485-hajrnur1	21	24	as	as	IN
cord-279485-hajrnur1	21	25	the	the	DT
cord-279485-hajrnur1	21	26	first	first	JJ
cord-279485-hajrnur1	21	27	case	case	NN
cord-279485-hajrnur1	21	28	was	be	VBD
cord-279485-hajrnur1	21	29	reported	report	VBN
cord-279485-hajrnur1	21	30	to	to	IN
cord-279485-hajrnur1	21	31	the	the	DT
cord-279485-hajrnur1	21	32	WHO	WHO	NNP
cord-279485-hajrnur1	21	33	China	China	NNP
cord-279485-hajrnur1	21	34	office	office	NN
cord-279485-hajrnur1	21	35	on	on	IN
cord-279485-hajrnur1	21	36	December	December	NNP
cord-279485-hajrnur1	21	37	31	31	CD
cord-279485-hajrnur1	21	38	,	,	,
cord-279485-hajrnur1	21	39	2019	2019	CD
cord-279485-hajrnur1	21	40	[	[	-LRB-
cord-279485-hajrnur1	21	41	2	2	CD
cord-279485-hajrnur1	21	42	]	]	-RRB-
cord-279485-hajrnur1	21	43	.	.	.
cord-279485-hajrnur1	22	1	COVID-19	COVID-19	NNP
cord-279485-hajrnur1	22	2	is	be	VBZ
cord-279485-hajrnur1	22	3	a	a	DT
cord-279485-hajrnur1	22	4	coronavirus	coronavirus	NN
cord-279485-hajrnur1	22	5	SARS	SARS	NNP
cord-279485-hajrnur1	22	6	-	-	HYPH
cord-279485-hajrnur1	22	7	CoV-2	CoV-2	NNP
cord-279485-hajrnur1	22	8	which	which	WDT
cord-279485-hajrnur1	22	9	started	start	VBD
cord-279485-hajrnur1	22	10	in	in	IN
cord-279485-hajrnur1	22	11	Wuhan	Wuhan	NNP
cord-279485-hajrnur1	22	12	,	,	,
cord-279485-hajrnur1	22	13	China	China	NNP
cord-279485-hajrnur1	22	14	and	and	CC
cord-279485-hajrnur1	22	15	it	-PRON-	PRP
cord-279485-hajrnur1	22	16	is	be	VBZ
cord-279485-hajrnur1	22	17	short	short	JJ
cord-279485-hajrnur1	22	18	for	for	IN
cord-279485-hajrnur1	22	19	coronavirus	coronavirus	NN
cord-279485-hajrnur1	22	20	disease	disease	NN
cord-279485-hajrnur1	22	21	first	first	RB
cord-279485-hajrnur1	22	22	found	find	VBD
cord-279485-hajrnur1	22	23	in	in	IN
cord-279485-hajrnur1	22	24	2019	2019	CD
cord-279485-hajrnur1	22	25	.	.	.
cord-279485-hajrnur1	23	1	The	the	DT
cord-279485-hajrnur1	23	2	virus	virus	NN
cord-279485-hajrnur1	23	3	jumped	jump	VBD
cord-279485-hajrnur1	23	4	species	specie	NNS
cord-279485-hajrnur1	23	5	to	to	IN
cord-279485-hajrnur1	23	6	humans	human	NNS
cord-279485-hajrnur1	23	7	originating	originate	VBG
cord-279485-hajrnur1	23	8	in	in	IN
cord-279485-hajrnur1	23	9	the	the	DT
cord-279485-hajrnur1	23	10	pangolins	pangolin	NNS
cord-279485-hajrnur1	23	11	or	or	CC
cord-279485-hajrnur1	23	12	horseshoe	horseshoe	NN
cord-279485-hajrnur1	23	13	bats	bat	NNS
cord-279485-hajrnur1	23	14	[	[	-LRB-
cord-279485-hajrnur1	23	15	3	3	CD
cord-279485-hajrnur1	23	16	]	]	-RRB-
cord-279485-hajrnur1	23	17	.	.	.
cord-279485-hajrnur1	24	1	The	the	DT
cord-279485-hajrnur1	24	2	pangolins	pangolin	NNS
cord-279485-hajrnur1	24	3	are	be	VBP
cord-279485-hajrnur1	24	4	widely	widely	RB
cord-279485-hajrnur1	24	5	smuggled	smuggle	VBN
cord-279485-hajrnur1	24	6	and	and	CC
cord-279485-hajrnur1	24	7	sold	sell	VBN
cord-279485-hajrnur1	24	8	in	in	IN
cord-279485-hajrnur1	24	9	wet	wet	JJ
cord-279485-hajrnur1	24	10	markets	market	NNS
cord-279485-hajrnur1	24	11	illegally	illegally	RB
cord-279485-hajrnur1	24	12	in	in	IN
cord-279485-hajrnur1	24	13	China	China	NNP
cord-279485-hajrnur1	24	14	.	.	.
cord-279485-hajrnur1	25	1	The	the	DT
cord-279485-hajrnur1	25	2	signs	sign	NNS
cord-279485-hajrnur1	25	3	and	and	CC
cord-279485-hajrnur1	25	4	symptoms	symptom	NNS
cord-279485-hajrnur1	25	5	of	of	IN
cord-279485-hajrnur1	25	6	COVID-19	COVID-19	NNP
cord-279485-hajrnur1	25	7	vary	vary	VBP
cord-279485-hajrnur1	25	8	from	from	IN
cord-279485-hajrnur1	25	9	no	no	DT
cord-279485-hajrnur1	25	10	symptoms	symptom	NNS
cord-279485-hajrnur1	25	11	(	(	-LRB-
cord-279485-hajrnur1	25	12	carrier	carrier	NN
cord-279485-hajrnur1	25	13	)	)	-RRB-
cord-279485-hajrnur1	25	14	,	,	,
cord-279485-hajrnur1	25	15	to	to	IN
cord-279485-hajrnur1	25	16	a	a	DT
cord-279485-hajrnur1	25	17	mild	mild	JJ
cord-279485-hajrnur1	25	18	respiratory	respiratory	JJ
cord-279485-hajrnur1	25	19	tract	tract	NN
cord-279485-hajrnur1	25	20	infection	infection	NN
cord-279485-hajrnur1	25	21	to	to	IN
cord-279485-hajrnur1	25	22	fever	fever	NN
cord-279485-hajrnur1	25	23	,	,	,
cord-279485-hajrnur1	25	24	cough	cough	NN
cord-279485-hajrnur1	25	25	,	,	,
cord-279485-hajrnur1	25	26	and	and	CC
cord-279485-hajrnur1	25	27	bilateral	bilateral	JJ
cord-279485-hajrnur1	25	28	pneumonitis	pneumonitis	NN
cord-279485-hajrnur1	25	29	.	.	.
cord-279485-hajrnur1	26	1	The	the	DT
cord-279485-hajrnur1	26	2	latter	latter	NN
cord-279485-hajrnur1	26	3	can	can	MD
cord-279485-hajrnur1	26	4	result	result	VB
cord-279485-hajrnur1	26	5	in	in	IN
cord-279485-hajrnur1	26	6	death	death	NN
cord-279485-hajrnur1	26	7	with	with	IN
cord-279485-hajrnur1	26	8	a	a	DT
cord-279485-hajrnur1	26	9	varying	vary	VBG
cord-279485-hajrnur1	26	10	mortality	mortality	NN
cord-279485-hajrnur1	26	11	rate	rate	NN
cord-279485-hajrnur1	26	12	[	[	-LRB-
cord-279485-hajrnur1	26	13	4	4	CD
cord-279485-hajrnur1	26	14	]	]	-RRB-
cord-279485-hajrnur1	26	15	.	.	.
cord-279485-hajrnur1	27	1	There	there	EX
cord-279485-hajrnur1	27	2	are	be	VBP
cord-279485-hajrnur1	27	3	six	six	CD
cord-279485-hajrnur1	27	4	other	other	JJ
cord-279485-hajrnur1	27	5	strains	strain	NNS
cord-279485-hajrnur1	27	6	of	of	IN
cord-279485-hajrnur1	27	7	coronavirus	coronavirus	NN
cord-279485-hajrnur1	27	8	including	include	VBG
cord-279485-hajrnur1	27	9	four	four	CD
cord-279485-hajrnur1	27	10	which	which	WDT
cord-279485-hajrnur1	27	11	cause	cause	VBP
cord-279485-hajrnur1	27	12	only	only	RB
cord-279485-hajrnur1	27	13	mild	mild	JJ
cord-279485-hajrnur1	27	14	colds	cold	NNS
cord-279485-hajrnur1	27	15	and	and	CC
cord-279485-hajrnur1	27	16	severe	severe	JJ
cord-279485-hajrnur1	27	17	acute	acute	JJ
cord-279485-hajrnur1	27	18	respiratory	respiratory	JJ
cord-279485-hajrnur1	27	19	syndrome	syndrome	NN
cord-279485-hajrnur1	27	20	(	(	-LRB-
cord-279485-hajrnur1	27	21	SARS	SARS	NNP
cord-279485-hajrnur1	27	22	CoV	CoV	NNP
cord-279485-hajrnur1	27	23	)	)	-RRB-
cord-279485-hajrnur1	27	24	which	which	WDT
cord-279485-hajrnur1	27	25	had	have	VBD
cord-279485-hajrnur1	27	26	an	an	DT
cord-279485-hajrnur1	27	27	outbreak	outbreak	NN
cord-279485-hajrnur1	27	28	in	in	IN
cord-279485-hajrnur1	27	29	2003	2003	CD
cord-279485-hajrnur1	27	30	with	with	IN
cord-279485-hajrnur1	27	31	approximately	approximately	RB
cord-279485-hajrnur1	27	32	a	a	DT
cord-279485-hajrnur1	27	33	10	10	CD
cord-279485-hajrnur1	27	34	%	%	NN
cord-279485-hajrnur1	27	35	mortality	mortality	NN
cord-279485-hajrnur1	27	36	,	,	,
cord-279485-hajrnur1	27	37	and	and	CC
cord-279485-hajrnur1	27	38	Middle	Middle	NNP
cord-279485-hajrnur1	27	39	East	East	NNP
cord-279485-hajrnur1	27	40	respiratory	respiratory	JJ
cord-279485-hajrnur1	27	41	syndrome	syndrome	NN
cord-279485-hajrnur1	27	42	(	(	-LRB-
cord-279485-hajrnur1	27	43	MERS	MERS	NNP
cord-279485-hajrnur1	27	44	CoV	CoV	NNP
cord-279485-hajrnur1	27	45	)	)	-RRB-
cord-279485-hajrnur1	27	46	which	which	WDT
cord-279485-hajrnur1	27	47	is	be	VBZ
cord-279485-hajrnur1	27	48	still	still	RB
cord-279485-hajrnur1	27	49	endemic	endemic	JJ
cord-279485-hajrnur1	27	50	[	[	-LRB-
cord-279485-hajrnur1	27	51	5	5	CD
cord-279485-hajrnur1	27	52	]	]	-RRB-
cord-279485-hajrnur1	27	53	.	.	.
cord-279485-hajrnur1	28	1	The	the	DT
cord-279485-hajrnur1	28	2	risk	risk	NN
cord-279485-hajrnur1	28	3	factors	factor	NNS
cord-279485-hajrnur1	28	4	are	be	VBP
cord-279485-hajrnur1	28	5	age	age	NN
cord-279485-hajrnur1	28	6	,	,	,
cord-279485-hajrnur1	28	7	comorbidities	comorbiditie	NNS
cord-279485-hajrnur1	28	8	including	include	VBG
cord-279485-hajrnur1	28	9	chronic	chronic	JJ
cord-279485-hajrnur1	28	10	obstructive	obstructive	JJ
cord-279485-hajrnur1	28	11	lung	lung	NN
cord-279485-hajrnur1	28	12	disease	disease	NN
cord-279485-hajrnur1	28	13	(	(	-LRB-
cord-279485-hajrnur1	28	14	COPD	COPD	NNP
cord-279485-hajrnur1	28	15	)	)	-RRB-
cord-279485-hajrnur1	28	16	,	,	,
cord-279485-hajrnur1	28	17	diabetes	diabete	VBZ
cord-279485-hajrnur1	28	18	mellitus	mellitus	NN
cord-279485-hajrnur1	28	19	,	,	,
cord-279485-hajrnur1	28	20	and	and	CC
cord-279485-hajrnur1	28	21	coronary	coronary	JJ
cord-279485-hajrnur1	28	22	artery	artery	NN
cord-279485-hajrnur1	28	23	disease	disease	NN
cord-279485-hajrnur1	28	24	.	.	.
cord-279485-hajrnur1	29	1	Immune	immune	NN
cord-279485-hajrnur1	29	2	-	-	HYPH
cord-279485-hajrnur1	29	3	suppressed	suppress	VBN
cord-279485-hajrnur1	29	4	patients	patient	NNS
cord-279485-hajrnur1	29	5	are	be	VBP
cord-279485-hajrnur1	29	6	also	also	RB
cord-279485-hajrnur1	29	7	thought	think	VBN
cord-279485-hajrnur1	29	8	to	to	TO
cord-279485-hajrnur1	29	9	be	be	VB
cord-279485-hajrnur1	29	10	at	at	IN
cord-279485-hajrnur1	29	11	a	a	DT
cord-279485-hajrnur1	29	12	higher	high	JJR
cord-279485-hajrnur1	29	13	risk	risk	NN
cord-279485-hajrnur1	29	14	for	for	IN
cord-279485-hajrnur1	29	15	worse	bad	JJR
cord-279485-hajrnur1	29	16	outcomes	outcome	NNS
cord-279485-hajrnur1	29	17	.	.	.
cord-279485-hajrnur1	30	1	It	-PRON-	PRP
cord-279485-hajrnur1	30	2	is	be	VBZ
cord-279485-hajrnur1	30	3	uncertain	uncertain	JJ
cord-279485-hajrnur1	30	4	if	if	IN
cord-279485-hajrnur1	30	5	patients	patient	NNS
cord-279485-hajrnur1	30	6	with	with	IN
cord-279485-hajrnur1	30	7	autoimmune	autoimmune	JJ
cord-279485-hajrnur1	30	8	rheumatic	rheumatic	JJ
cord-279485-hajrnur1	30	9	diseases	disease	NNS
cord-279485-hajrnur1	30	10	are	be	VBP
cord-279485-hajrnur1	30	11	at	at	IN
cord-279485-hajrnur1	30	12	a	a	DT
cord-279485-hajrnur1	30	13	higher	high	JJR
cord-279485-hajrnur1	30	14	risk	risk	NN
cord-279485-hajrnur1	30	15	to	to	TO
cord-279485-hajrnur1	30	16	contract	contract	VB
cord-279485-hajrnur1	30	17	the	the	DT
cord-279485-hajrnur1	30	18	virus	virus	NN
cord-279485-hajrnur1	30	19	,	,	,
cord-279485-hajrnur1	30	20	and	and	CC
cord-279485-hajrnur1	30	21	if	if	IN
cord-279485-hajrnur1	30	22	they	-PRON-	PRP
cord-279485-hajrnur1	30	23	are	be	VBP
cord-279485-hajrnur1	30	24	infected	infect	VBN
cord-279485-hajrnur1	30	25	whether	whether	IN
cord-279485-hajrnur1	30	26	they	-PRON-	PRP
cord-279485-hajrnur1	30	27	have	have	VBP
cord-279485-hajrnur1	30	28	worse	bad	JJR
cord-279485-hajrnur1	30	29	outcomes	outcome	NNS
cord-279485-hajrnur1	30	30	.	.	.
cord-279485-hajrnur1	31	1	There	there	EX
cord-279485-hajrnur1	31	2	are	be	VBP
cord-279485-hajrnur1	31	3	also	also	RB
cord-279485-hajrnur1	31	4	different	different	JJ
cord-279485-hajrnur1	31	5	degrees	degree	NNS
cord-279485-hajrnur1	31	6	of	of	IN
cord-279485-hajrnur1	31	7	immune	immune	JJ
cord-279485-hajrnur1	31	8	suppression	suppression	NN
cord-279485-hajrnur1	31	9	.	.	.
cord-279485-hajrnur1	32	1	We	-PRON-	PRP
cord-279485-hajrnur1	32	2	can	can	MD
cord-279485-hajrnur1	32	3	consider	consider	VB
cord-279485-hajrnur1	32	4	the	the	DT
cord-279485-hajrnur1	32	5	host	host	NN
cord-279485-hajrnur1	32	6	factors	factor	NNS
cord-279485-hajrnur1	32	7	and	and	CC
cord-279485-hajrnur1	32	8	treatment	treatment	NN
cord-279485-hajrnur1	32	9	.	.	.
cord-279485-hajrnur1	33	1	Some	some	DT
cord-279485-hajrnur1	33	2	patients	patient	NNS
cord-279485-hajrnur1	33	3	will	will	MD
cord-279485-hajrnur1	33	4	have	have	VB
cord-279485-hajrnur1	33	5	more	more	JJR
cord-279485-hajrnur1	33	6	infections	infection	NNS
cord-279485-hajrnur1	33	7	due	due	JJ
cord-279485-hajrnur1	33	8	to	to	IN
cord-279485-hajrnur1	33	9	their	-PRON-	PRP$
cord-279485-hajrnur1	33	10	rheumatic	rheumatic	JJ
cord-279485-hajrnur1	33	11	disease	disease	NN
cord-279485-hajrnur1	33	12	(	(	-LRB-
cord-279485-hajrnur1	33	13	such	such	JJ
cord-279485-hajrnur1	33	14	as	as	IN
cord-279485-hajrnur1	33	15	rheumatoid	rheumatoid	JJ
cord-279485-hajrnur1	33	16	arthritis	arthritis	NN
cord-279485-hajrnur1	33	17	,	,	,
cord-279485-hajrnur1	33	18	systemic	systemic	JJ
cord-279485-hajrnur1	33	19	lupus	lupus	NN
cord-279485-hajrnur1	33	20	erythematosus	erythematosus	NN
cord-279485-hajrnur1	33	21	,	,	,
cord-279485-hajrnur1	33	22	systemic	systemic	JJ
cord-279485-hajrnur1	33	23	sclerosis	sclerosis	NN
cord-279485-hajrnur1	33	24	,	,	,
cord-279485-hajrnur1	33	25	other	other	JJ
cord-279485-hajrnur1	33	26	connective	connective	JJ
cord-279485-hajrnur1	33	27	tissue	tissue	NN
cord-279485-hajrnur1	33	28	diseases	disease	NNS
cord-279485-hajrnur1	33	29	,	,	,
cord-279485-hajrnur1	33	30	and	and	CC
cord-279485-hajrnur1	33	31	vasculitis	vasculitis	NN
cord-279485-hajrnur1	33	32	)	)	-RRB-
cord-279485-hajrnur1	33	33	.	.	.
cord-279485-hajrnur1	34	1	Additionally	additionally	RB
cord-279485-hajrnur1	34	2	,	,	,
cord-279485-hajrnur1	34	3	corticosteroids	corticosteroid	NNS
cord-279485-hajrnur1	34	4	(	(	-LRB-
cord-279485-hajrnur1	34	5	especially	especially	RB
cord-279485-hajrnur1	34	6	high	high	JJ
cord-279485-hajrnur1	34	7	dose	dose	NN
cord-279485-hajrnur1	34	8	)	)	-RRB-
cord-279485-hajrnur1	34	9	increase	increase	VB
cord-279485-hajrnur1	34	10	the	the	DT
cord-279485-hajrnur1	34	11	risk	risk	NN
cord-279485-hajrnur1	34	12	of	of	IN
cord-279485-hajrnur1	34	13	infection	infection	NN
cord-279485-hajrnur1	34	14	.	.	.
cord-279485-hajrnur1	35	1	It	-PRON-	PRP
cord-279485-hajrnur1	35	2	is	be	VBZ
cord-279485-hajrnur1	35	3	less	less	RBR
cord-279485-hajrnur1	35	4	certain	certain	JJ
cord-279485-hajrnur1	35	5	how	how	WRB
cord-279485-hajrnur1	35	6	much	much	JJ
cord-279485-hajrnur1	35	7	of	of	IN
cord-279485-hajrnur1	35	8	an	an	DT
cord-279485-hajrnur1	35	9	increased	increase	VBN
cord-279485-hajrnur1	35	10	risk	risk	NN
cord-279485-hajrnur1	35	11	immune	immune	JJ
cord-279485-hajrnur1	35	12	modulators	modulator	NNS
cord-279485-hajrnur1	35	13	such	such	JJ
cord-279485-hajrnur1	35	14	as	as	IN
cord-279485-hajrnur1	35	15	methotrexate	methotrexate	NNP
cord-279485-hajrnur1	35	16	,	,	,
cord-279485-hajrnur1	35	17	azathioprine	azathioprine	NN
cord-279485-hajrnur1	35	18	,	,	,
cord-279485-hajrnur1	35	19	biologics	biologic	NNS
cord-279485-hajrnur1	35	20	,	,	,
cord-279485-hajrnur1	35	21	and	and	CC
cord-279485-hajrnur1	35	22	Janus	Janus	NNP
cord-279485-hajrnur1	35	23	kinase	kinase	NN
cord-279485-hajrnur1	35	24	inhibitors	inhibitor	NNS
cord-279485-hajrnur1	35	25	have	have	VBP
cord-279485-hajrnur1	35	26	on	on	IN
cord-279485-hajrnur1	35	27	the	the	DT
cord-279485-hajrnur1	35	28	outcomes	outcome	NNS
cord-279485-hajrnur1	35	29	of	of	IN
cord-279485-hajrnur1	35	30	COVID-19	covid-19	NN
cord-279485-hajrnur1	35	31	but	but	CC
cord-279485-hajrnur1	35	32	to	to	IN
cord-279485-hajrnur1	35	33	date	date	NN
cord-279485-hajrnur1	35	34	this	this	DT
cord-279485-hajrnur1	35	35	is	be	VBZ
cord-279485-hajrnur1	35	36	not	not	RB
cord-279485-hajrnur1	35	37	a	a	DT
cord-279485-hajrnur1	35	38	major	major	JJ
cord-279485-hajrnur1	35	39	risk	risk	NN
cord-279485-hajrnur1	35	40	[	[	-LRB-
cord-279485-hajrnur1	35	41	6	6	CD
cord-279485-hajrnur1	35	42	,	,	,
cord-279485-hajrnur1	35	43	7	7	CD
cord-279485-hajrnur1	35	44	]	]	-RRB-
cord-279485-hajrnur1	35	45	.	.	.
cord-279485-hajrnur1	36	1	Rheumatology	rheumatology	NN
cord-279485-hajrnur1	36	2	patients	patient	NNS
cord-279485-hajrnur1	36	3	with	with	IN
cord-279485-hajrnur1	36	4	systemic	systemic	JJ
cord-279485-hajrnur1	36	5	autoimmune	autoimmune	JJ
cord-279485-hajrnur1	36	6	diseases	disease	NNS
cord-279485-hajrnur1	36	7	may	may	MD
cord-279485-hajrnur1	36	8	have	have	VB
cord-279485-hajrnur1	36	9	several	several	JJ
cord-279485-hajrnur1	36	10	concerns	concern	NNS
cord-279485-hajrnur1	36	11	.	.	.
cord-279485-hajrnur1	37	1	They	-PRON-	PRP
cord-279485-hajrnur1	37	2	are	be	VBP
cord-279485-hajrnur1	37	3	uncertain	uncertain	JJ
cord-279485-hajrnur1	37	4	if	if	IN
cord-279485-hajrnur1	37	5	they	-PRON-	PRP
cord-279485-hajrnur1	37	6	should	should	MD
cord-279485-hajrnur1	37	7	be	be	VB
cord-279485-hajrnur1	37	8	working	work	VBG
cord-279485-hajrnur1	37	9	if	if	IN
cord-279485-hajrnur1	37	10	they	-PRON-	PRP
cord-279485-hajrnur1	37	11	are	be	VBP
cord-279485-hajrnur1	37	12	employed	employ	VBN
cord-279485-hajrnur1	37	13	in	in	IN
cord-279485-hajrnur1	37	14	health	health	NN
cord-279485-hajrnur1	37	15	care	care	NN
cord-279485-hajrnur1	37	16	or	or	CC
cord-279485-hajrnur1	37	17	other	other	JJ
cord-279485-hajrnur1	37	18	frontline	frontline	JJ
cord-279485-hajrnur1	37	19	jobs	job	NNS
cord-279485-hajrnur1	37	20	due	due	JJ
cord-279485-hajrnur1	37	21	to	to	IN
cord-279485-hajrnur1	37	22	the	the	DT
cord-279485-hajrnur1	37	23	risk	risk	NN
cord-279485-hajrnur1	37	24	of	of	IN
cord-279485-hajrnur1	37	25	getting	get	VBG
cord-279485-hajrnur1	37	26	ill	ill	JJ
cord-279485-hajrnur1	37	27	.	.	.
cord-279485-hajrnur1	38	1	They	-PRON-	PRP
cord-279485-hajrnur1	38	2	do	do	VBP
cord-279485-hajrnur1	38	3	not	not	RB
cord-279485-hajrnur1	38	4	know	know	VB
cord-279485-hajrnur1	38	5	if	if	IN
cord-279485-hajrnur1	38	6	they	-PRON-	PRP
cord-279485-hajrnur1	38	7	should	should	MD
cord-279485-hajrnur1	38	8	continue	continue	VB
cord-279485-hajrnur1	38	9	with	with	IN
cord-279485-hajrnur1	38	10	their	-PRON-	PRP$
cord-279485-hajrnur1	38	11	immune	immune	JJ
cord-279485-hajrnur1	38	12	suppressive	suppressive	JJ
cord-279485-hajrnur1	38	13	medications	medication	NNS
cord-279485-hajrnur1	38	14	and	and	CC
cord-279485-hajrnur1	38	15	they	-PRON-	PRP
cord-279485-hajrnur1	38	16	are	be	VBP
cord-279485-hajrnur1	38	17	concerned	concerned	JJ
cord-279485-hajrnur1	38	18	about	about	IN
cord-279485-hajrnur1	38	19	drug	drug	NN
cord-279485-hajrnur1	38	20	shortages	shortage	NNS
cord-279485-hajrnur1	38	21	of	of	IN
cord-279485-hajrnur1	38	22	hydroxychloroquine	hydroxychloroquine	NN
cord-279485-hajrnur1	38	23	.	.	.
cord-279485-hajrnur1	39	1	The	the	DT
cord-279485-hajrnur1	39	2	advice	advice	NN
cord-279485-hajrnur1	39	3	that	that	WDT
cord-279485-hajrnur1	39	4	is	be	VBZ
cord-279485-hajrnur1	39	5	given	give	VBN
cord-279485-hajrnur1	39	6	to	to	IN
cord-279485-hajrnur1	39	7	patients	patient	NNS
cord-279485-hajrnur1	39	8	is	be	VBZ
cord-279485-hajrnur1	39	9	tailored	tailor	VBN
cord-279485-hajrnur1	39	10	to	to	IN
cord-279485-hajrnur1	39	11	the	the	DT
cord-279485-hajrnur1	39	12	individual	individual	NN
cord-279485-hajrnur1	39	13	.	.	.
cord-279485-hajrnur1	40	1	The	the	DT
cord-279485-hajrnur1	40	2	Canadian	Canadian	NNP
cord-279485-hajrnur1	40	3	Rheumatology	Rheumatology	NNP
cord-279485-hajrnur1	40	4	Association	Association	NNP
cord-279485-hajrnur1	40	5	has	have	VBZ
cord-279485-hajrnur1	40	6	a	a	DT
cord-279485-hajrnur1	40	7	statement	statement	NN
cord-279485-hajrnur1	40	8	that	that	WDT
cord-279485-hajrnur1	40	9	includes	include	VBZ
cord-279485-hajrnur1	40	10	patients	patient	NNS
cord-279485-hajrnur1	40	11	should	should	MD
cord-279485-hajrnur1	40	12	not	not	RB
cord-279485-hajrnur1	40	13	stop	stop	VB
cord-279485-hajrnur1	40	14	their	-PRON-	PRP$
cord-279485-hajrnur1	40	15	rheumatic	rheumatic	JJ
cord-279485-hajrnur1	40	16	medications	medication	NNS
cord-279485-hajrnur1	40	17	unless	unless	IN
cord-279485-hajrnur1	40	18	if	if	IN
cord-279485-hajrnur1	40	19	ill	ill	JJ
cord-279485-hajrnur1	40	20	with	with	IN
cord-279485-hajrnur1	40	21	a	a	DT
cord-279485-hajrnur1	40	22	high	high	JJ
cord-279485-hajrnur1	40	23	fever	fever	NN
cord-279485-hajrnur1	40	24	or	or	CC
cord-279485-hajrnur1	40	25	serious	serious	JJ
cord-279485-hajrnur1	40	26	infection	infection	NN
cord-279485-hajrnur1	40	27	.	.	.
cord-279485-hajrnur1	41	1	They	-PRON-	PRP
cord-279485-hajrnur1	41	2	should	should	MD
cord-279485-hajrnur1	41	3	not	not	RB
cord-279485-hajrnur1	41	4	suddenly	suddenly	RB
cord-279485-hajrnur1	41	5	stop	stop	VB
cord-279485-hajrnur1	41	6	their	-PRON-	PRP$
cord-279485-hajrnur1	41	7	corticosteroids	corticosteroid	NNS
cord-279485-hajrnur1	41	8	if	if	IN
cord-279485-hajrnur1	41	9	on	on	IN
cord-279485-hajrnur1	41	10	them	-PRON-	PRP
cord-279485-hajrnur1	41	11	chronically	chronically	RB
cord-279485-hajrnur1	41	12	.	.	.
cord-279485-hajrnur1	42	1	They	-PRON-	PRP
cord-279485-hajrnur1	42	2	should	should	MD
cord-279485-hajrnur1	42	3	not	not	RB
cord-279485-hajrnur1	42	4	seek	seek	VB
cord-279485-hajrnur1	42	5	medical	medical	JJ
cord-279485-hajrnur1	42	6	attention	attention	NN
cord-279485-hajrnur1	42	7	for	for	IN
cord-279485-hajrnur1	42	8	suspected	suspect	VBN
cord-279485-hajrnur1	42	9	COVID-19	covid-19	JJ
cord-279485-hajrnur1	42	10	infection	infection	NN
cord-279485-hajrnur1	42	11	unless	unless	IN
cord-279485-hajrnur1	42	12	if	if	IN
cord-279485-hajrnur1	42	13	they	-PRON-	PRP
cord-279485-hajrnur1	42	14	meet	meet	VBP
cord-279485-hajrnur1	42	15	the	the	DT
cord-279485-hajrnur1	42	16	case	case	NN
cord-279485-hajrnur1	42	17	definition	definition	NN
cord-279485-hajrnur1	42	18	for	for	IN
cord-279485-hajrnur1	42	19	testing	testing	NN
cord-279485-hajrnur1	42	20	(	(	-LRB-
cord-279485-hajrnur1	42	21	which	which	WDT
cord-279485-hajrnur1	42	22	is	be	VBZ
cord-279485-hajrnur1	42	23	region	region	NN
cord-279485-hajrnur1	42	24	specific	specific	JJ
cord-279485-hajrnur1	42	25	but	but	CC
cord-279485-hajrnur1	42	26	may	may	MD
cord-279485-hajrnur1	42	27	include	include	VB
cord-279485-hajrnur1	42	28	fever	fever	NN
cord-279485-hajrnur1	42	29	and	and	CC
cord-279485-hajrnur1	42	30	dyspnea	dyspnea	NN
cord-279485-hajrnur1	42	31	and	and	CC
cord-279485-hajrnur1	42	32	cough	cough	NN
cord-279485-hajrnur1	42	33	)	)	-RRB-
cord-279485-hajrnur1	42	34	.	.	.
cord-279485-hajrnur1	43	1	If	if	IN
cord-279485-hajrnur1	43	2	they	-PRON-	PRP
cord-279485-hajrnur1	43	3	go	go	VBP
cord-279485-hajrnur1	43	4	to	to	IN
cord-279485-hajrnur1	43	5	the	the	DT
cord-279485-hajrnur1	43	6	emergency	emergency	NN
cord-279485-hajrnur1	43	7	room	room	NN
cord-279485-hajrnur1	43	8	,	,	,
cord-279485-hajrnur1	43	9	they	-PRON-	PRP
cord-279485-hajrnur1	43	10	should	should	MD
cord-279485-hajrnur1	43	11	say	say	VB
cord-279485-hajrnur1	43	12	they	-PRON-	PRP
cord-279485-hajrnur1	43	13	are	be	VBP
cord-279485-hajrnur1	43	14	receiving	receive	VBG
cord-279485-hajrnur1	43	15	medications	medication	NNS
cord-279485-hajrnur1	43	16	that	that	WDT
cord-279485-hajrnur1	43	17	may	may	MD
cord-279485-hajrnur1	43	18	increase	increase	VB
cord-279485-hajrnur1	43	19	immune	immune	JJ
cord-279485-hajrnur1	43	20	suppression	suppression	NN
cord-279485-hajrnur1	43	21	.	.	.
cord-279485-hajrnur1	44	1	Like	like	IN
cord-279485-hajrnur1	44	2	all	all	DT
cord-279485-hajrnur1	44	3	patients	patient	NNS
cord-279485-hajrnur1	44	4	,	,	,
cord-279485-hajrnur1	44	5	they	-PRON-	PRP
cord-279485-hajrnur1	44	6	should	should	MD
cord-279485-hajrnur1	44	7	cough	cough	VB
cord-279485-hajrnur1	44	8	into	into	IN
cord-279485-hajrnur1	44	9	their	-PRON-	PRP$
cord-279485-hajrnur1	44	10	arm	arm	NN
cord-279485-hajrnur1	44	11	or	or	CC
cord-279485-hajrnur1	44	12	a	a	DT
cord-279485-hajrnur1	44	13	tissue	tissue	NN
cord-279485-hajrnur1	44	14	,	,	,
cord-279485-hajrnur1	44	15	wash	wash	VB
cord-279485-hajrnur1	44	16	hands	hand	NNS
cord-279485-hajrnur1	44	17	frequently	frequently	RB
cord-279485-hajrnur1	44	18	(	(	-LRB-
cord-279485-hajrnur1	44	19	for	for	IN
cord-279485-hajrnur1	44	20	20	20	CD
cord-279485-hajrnur1	44	21	s	s	NNS
cord-279485-hajrnur1	44	22	each	each	DT
cord-279485-hajrnur1	44	23	time	time	NN
cord-279485-hajrnur1	44	24	)	)	-RRB-
cord-279485-hajrnur1	44	25	especially	especially	RB
cord-279485-hajrnur1	44	26	after	after	IN
cord-279485-hajrnur1	44	27	returning	return	VBG
cord-279485-hajrnur1	44	28	home	home	RB
cord-279485-hajrnur1	44	29	if	if	IN
cord-279485-hajrnur1	44	30	they	-PRON-	PRP
cord-279485-hajrnur1	44	31	have	have	VBP
cord-279485-hajrnur1	44	32	been	be	VBN
cord-279485-hajrnur1	44	33	out	out	IN
cord-279485-hajrnur1	44	34	of	of	IN
cord-279485-hajrnur1	44	35	their	-PRON-	PRP$
cord-279485-hajrnur1	44	36	home	home	NN
cord-279485-hajrnur1	44	37	,	,	,
cord-279485-hajrnur1	44	38	avoid	avoid	VB
cord-279485-hajrnur1	44	39	touching	touch	VBG
cord-279485-hajrnur1	44	40	their	-PRON-	PRP$
cord-279485-hajrnur1	44	41	face	face	NN
cord-279485-hajrnur1	44	42	(	(	-LRB-
cord-279485-hajrnur1	44	43	especially	especially	RB
cord-279485-hajrnur1	44	44	nose	nose	NN
cord-279485-hajrnur1	44	45	,	,	,
cord-279485-hajrnur1	44	46	mouth	mouth	NN
cord-279485-hajrnur1	44	47	,	,	,
cord-279485-hajrnur1	44	48	and	and	CC
cord-279485-hajrnur1	44	49	eyes	eye	NNS
cord-279485-hajrnur1	44	50	)	)	-RRB-
cord-279485-hajrnur1	44	51	,	,	,
cord-279485-hajrnur1	44	52	avoid	avoid	VB
cord-279485-hajrnur1	44	53	crowds	crowd	NNS
cord-279485-hajrnur1	44	54	,	,	,
cord-279485-hajrnur1	44	55	avoid	avoid	VB
cord-279485-hajrnur1	44	56	unnecessary	unnecessary	JJ
cord-279485-hajrnur1	44	57	travel	travel	NN
cord-279485-hajrnur1	44	58	,	,	,
cord-279485-hajrnur1	44	59	quarantine	quarantine	NN
cord-279485-hajrnur1	44	60	if	if	IN
cord-279485-hajrnur1	44	61	told	tell	VBN
cord-279485-hajrnur1	44	62	to	to	TO
cord-279485-hajrnur1	44	63	do	do	VB
cord-279485-hajrnur1	44	64	so	so	RB
cord-279485-hajrnur1	44	65	,	,	,
cord-279485-hajrnur1	44	66	and	and	CC
cord-279485-hajrnur1	44	67	to	to	TO
cord-279485-hajrnur1	44	68	get	get	VB
cord-279485-hajrnur1	44	69	the	the	DT
cord-279485-hajrnur1	44	70	flu	flu	NN
cord-279485-hajrnur1	44	71	shot	shot	NN
cord-279485-hajrnur1	44	72	if	if	IN
cord-279485-hajrnur1	44	73	not	not	RB
cord-279485-hajrnur1	44	74	already	already	RB
cord-279485-hajrnur1	44	75	received	receive	VBN
cord-279485-hajrnur1	44	76	as	as	IN
cord-279485-hajrnur1	44	77	influenza	influenza	NN
cord-279485-hajrnur1	44	78	is	be	VBZ
cord-279485-hajrnur1	44	79	still	still	RB
cord-279485-hajrnur1	44	80	present	present	JJ
cord-279485-hajrnur1	44	81	in	in	IN
cord-279485-hajrnur1	44	82	many	many	JJ
cord-279485-hajrnur1	44	83	jurisdictions	jurisdiction	NNS
cord-279485-hajrnur1	44	84	[	[	-LRB-
cord-279485-hajrnur1	44	85	8	8	CD
cord-279485-hajrnur1	44	86	]	]	-RRB-
cord-279485-hajrnur1	44	87	.	.	.
cord-279485-hajrnur1	45	1	Their	-PRON-	PRP$
cord-279485-hajrnur1	45	2	infection	infection	NN
cord-279485-hajrnur1	45	3	risk	risk	NN
cord-279485-hajrnur1	45	4	is	be	VBZ
cord-279485-hajrnur1	45	5	related	relate	VBN
cord-279485-hajrnur1	45	6	also	also	RB
cord-279485-hajrnur1	45	7	to	to	IN
cord-279485-hajrnur1	45	8	the	the	DT
cord-279485-hajrnur1	45	9	virulence	virulence	NN
cord-279485-hajrnur1	45	10	of	of	IN
cord-279485-hajrnur1	45	11	the	the	DT
cord-279485-hajrnur1	45	12	strain	strain	NN
cord-279485-hajrnur1	45	13	(	(	-LRB-
cord-279485-hajrnur1	45	14	and	and	CC
cord-279485-hajrnur1	45	15	there	there	EX
cord-279485-hajrnur1	45	16	have	have	VBP
cord-279485-hajrnur1	45	17	been	be	VBN
cord-279485-hajrnur1	45	18	two	two	CD
cord-279485-hajrnur1	45	19	strains	strain	NNS
cord-279485-hajrnur1	45	20	of	of	IN
cord-279485-hajrnur1	45	21	COVID-19	COVID-19	NNP
cord-279485-hajrnur1	45	22	identified	identify	VBN
cord-279485-hajrnur1	45	23	thus	thus	RB
cord-279485-hajrnur1	45	24	far	far	RB
cord-279485-hajrnur1	45	25	)	)	-RRB-
cord-279485-hajrnur1	45	26	and	and	CC
cord-279485-hajrnur1	45	27	the	the	DT
cord-279485-hajrnur1	45	28	dose	dose	NN
cord-279485-hajrnur1	45	29	of	of	IN
cord-279485-hajrnur1	45	30	the	the	DT
cord-279485-hajrnur1	45	31	exposure	exposure	NN
cord-279485-hajrnur1	45	32	which	which	WDT
cord-279485-hajrnur1	45	33	is	be	VBZ
cord-279485-hajrnur1	45	34	why	why	WRB
cord-279485-hajrnur1	45	35	health	health	NN
cord-279485-hajrnur1	45	36	care	care	NN
cord-279485-hajrnur1	45	37	workers	worker	NNS
cord-279485-hajrnur1	45	38	have	have	VBP
cord-279485-hajrnur1	45	39	a	a	DT
cord-279485-hajrnur1	45	40	higher	high	JJR
cord-279485-hajrnur1	45	41	risk	risk	NN
cord-279485-hajrnur1	45	42	of	of	IN
cord-279485-hajrnur1	45	43	poor	poor	JJ
cord-279485-hajrnur1	45	44	outcomes	outcome	NNS
cord-279485-hajrnur1	45	45	with	with	IN
cord-279485-hajrnur1	45	46	a	a	DT
cord-279485-hajrnur1	45	47	high	high	JJ
cord-279485-hajrnur1	45	48	mortality	mortality	NN
cord-279485-hajrnur1	45	49	already	already	RB
cord-279485-hajrnur1	45	50	reported	report	VBN
cord-279485-hajrnur1	45	51	in	in	IN
cord-279485-hajrnur1	45	52	Italy	Italy	NNP
cord-279485-hajrnur1	45	53	[	[	-LRB-
cord-279485-hajrnur1	45	54	9	9	CD
cord-279485-hajrnur1	45	55	]	]	-RRB-
cord-279485-hajrnur1	45	56	.	.	.
cord-279485-hajrnur1	46	1	Other	other	JJ
cord-279485-hajrnur1	46	2	medications	medication	NNS
cord-279485-hajrnur1	46	3	such	such	JJ
cord-279485-hajrnur1	46	4	as	as	IN
cord-279485-hajrnur1	46	5	NSAIDs	nsaid	NNS
cord-279485-hajrnur1	46	6	do	do	VBP
cord-279485-hajrnur1	46	7	not	not	RB
cord-279485-hajrnur1	46	8	alter	alter	VB
cord-279485-hajrnur1	46	9	the	the	DT
cord-279485-hajrnur1	46	10	course	course	NN
cord-279485-hajrnur1	46	11	of	of	IN
cord-279485-hajrnur1	46	12	COVID-19	COVID-19	NNP
cord-279485-hajrnur1	46	13	despite	despite	IN
cord-279485-hajrnur1	46	14	an	an	DT
cord-279485-hajrnur1	46	15	earlier	early	JJR
cord-279485-hajrnur1	46	16	report	report	NN
cord-279485-hajrnur1	46	17	that	that	IN
cord-279485-hajrnur1	46	18	ibuprofen	ibuprofen	NN
cord-279485-hajrnur1	46	19	use	use	NN
cord-279485-hajrnur1	46	20	caused	cause	VBD
cord-279485-hajrnur1	46	21	worse	bad	JJR
cord-279485-hajrnur1	46	22	outcomes	outcome	NNS
cord-279485-hajrnur1	46	23	[	[	-LRB-
cord-279485-hajrnur1	46	24	10	10	CD
cord-279485-hajrnur1	46	25	]	]	-RRB-
cord-279485-hajrnur1	46	26	.	.	.
cord-279485-hajrnur1	47	1	The	the	DT
cord-279485-hajrnur1	47	2	conclusions	conclusion	NNS
cord-279485-hajrnur1	47	3	were	be	VBD
cord-279485-hajrnur1	47	4	likely	likely	RB
cord-279485-hajrnur1	47	5	premature	premature	JJ
cord-279485-hajrnur1	47	6	(	(	-LRB-
cord-279485-hajrnur1	47	7	and	and	CC
cord-279485-hajrnur1	47	8	there	there	EX
cord-279485-hajrnur1	47	9	could	could	MD
cord-279485-hajrnur1	47	10	be	be	VB
cord-279485-hajrnur1	47	11	confounding	confound	VBG
cord-279485-hajrnur1	47	12	where	where	WRB
cord-279485-hajrnur1	47	13	people	people	NNS
cord-279485-hajrnur1	47	14	with	with	IN
cord-279485-hajrnur1	47	15	worse	bad	JJR
cord-279485-hajrnur1	47	16	fever	fever	NN
cord-279485-hajrnur1	47	17	or	or	CC
cord-279485-hajrnur1	47	18	myalgias	myalgia	NNS
cord-279485-hajrnur1	47	19	from	from	IN
cord-279485-hajrnur1	47	20	COVID-19	COVID-19	NNP
cord-279485-hajrnur1	47	21	would	would	MD
cord-279485-hajrnur1	47	22	be	be	VB
cord-279485-hajrnur1	47	23	more	more	RBR
cord-279485-hajrnur1	47	24	likely	likely	JJ
cord-279485-hajrnur1	47	25	to	to	TO
cord-279485-hajrnur1	47	26	take	take	VB
cord-279485-hajrnur1	47	27	an	an	DT
cord-279485-hajrnur1	47	28	NSAID	nsaid	NN
cord-279485-hajrnur1	47	29	than	than	IN
cord-279485-hajrnur1	47	30	those	those	DT
cord-279485-hajrnur1	47	31	with	with	IN
cord-279485-hajrnur1	47	32	milder	mild	JJR
cord-279485-hajrnur1	47	33	symptoms	symptom	NNS
cord-279485-hajrnur1	47	34	and	and	CC
cord-279485-hajrnur1	47	35	the	the	DT
cord-279485-hajrnur1	47	36	former	former	JJ
cord-279485-hajrnur1	47	37	would	would	MD
cord-279485-hajrnur1	47	38	be	be	VB
cord-279485-hajrnur1	47	39	expected	expect	VBN
cord-279485-hajrnur1	47	40	to	to	TO
cord-279485-hajrnur1	47	41	have	have	VB
cord-279485-hajrnur1	47	42	a	a	DT
cord-279485-hajrnur1	47	43	worse	bad	JJR
cord-279485-hajrnur1	47	44	outcome	outcome	NN
cord-279485-hajrnur1	47	45	.	.	.
cord-279485-hajrnur1	48	1	Antimalarial	antimalarial	JJ
cord-279485-hajrnur1	48	2	shortages	shortage	NNS
cord-279485-hajrnur1	48	3	(	(	-LRB-
cord-279485-hajrnur1	48	4	particularly	particularly	RB
cord-279485-hajrnur1	48	5	hydroxychloroquine	hydroxychloroquine	NNP
cord-279485-hajrnur1	48	6	as	as	IN
cord-279485-hajrnur1	48	7	chloroquine	chloroquine	NN
cord-279485-hajrnur1	48	8	was	be	VBD
cord-279485-hajrnur1	48	9	already	already	RB
cord-279485-hajrnur1	48	10	on	on	IN
cord-279485-hajrnur1	48	11	back	back	JJ
cord-279485-hajrnur1	48	12	order	order	NN
cord-279485-hajrnur1	48	13	in	in	IN
cord-279485-hajrnur1	48	14	many	many	JJ
cord-279485-hajrnur1	48	15	jurisdictions	jurisdiction	NNS
cord-279485-hajrnur1	48	16	)	)	-RRB-
cord-279485-hajrnur1	48	17	occurred	occur	VBD
cord-279485-hajrnur1	48	18	after	after	IN
cord-279485-hajrnur1	48	19	a	a	DT
cord-279485-hajrnur1	48	20	small	small	JJ
cord-279485-hajrnur1	48	21	publication	publication	NN
cord-279485-hajrnur1	48	22	may	may	MD
cord-279485-hajrnur1	48	23	have	have	VB
cord-279485-hajrnur1	48	24	shown	show	VBN
cord-279485-hajrnur1	48	25	that	that	IN
cord-279485-hajrnur1	48	26	the	the	DT
cord-279485-hajrnur1	48	27	viral	viral	JJ
cord-279485-hajrnur1	48	28	PCR	PCR	NNP
cord-279485-hajrnur1	48	29	decreased	decrease	VBD
cord-279485-hajrnur1	48	30	more	more	RBR
cord-279485-hajrnur1	48	31	in	in	IN
cord-279485-hajrnur1	48	32	patients	patient	NNS
cord-279485-hajrnur1	48	33	treated	treat	VBN
cord-279485-hajrnur1	48	34	with	with	IN
cord-279485-hajrnur1	48	35	hydroxychloroquine	hydroxychloroquine	NN
cord-279485-hajrnur1	48	36	than	than	IN
cord-279485-hajrnur1	48	37	controls	control	NNS
cord-279485-hajrnur1	48	38	[	[	-LRB-
cord-279485-hajrnur1	48	39	11	11	CD
cord-279485-hajrnur1	48	40	]	]	-RRB-
cord-279485-hajrnur1	48	41	.	.	.
cord-279485-hajrnur1	49	1	This	this	DT
cord-279485-hajrnur1	49	2	report	report	NN
cord-279485-hajrnur1	49	3	contained	contain	VBD
cord-279485-hajrnur1	49	4	20	20	CD
cord-279485-hajrnur1	49	5	patients	patient	NNS
cord-279485-hajrnur1	49	6	who	who	WP
cord-279485-hajrnur1	49	7	were	be	VBD
cord-279485-hajrnur1	49	8	treated	treat	VBN
cord-279485-hajrnur1	49	9	with	with	IN
cord-279485-hajrnur1	49	10	hydroxychloroquine	hydroxychloroquine	NN
cord-279485-hajrnur1	49	11	but	but	CC
cord-279485-hajrnur1	49	12	6	6	CD
cord-279485-hajrnur1	49	13	were	be	VBD
cord-279485-hajrnur1	49	14	not	not	RB
cord-279485-hajrnur1	49	15	included	include	VBN
cord-279485-hajrnur1	49	16	of	of	IN
cord-279485-hajrnur1	49	17	whom	whom	WP
cord-279485-hajrnur1	49	18	1	1	CD
cord-279485-hajrnur1	49	19	died	die	VBD
cord-279485-hajrnur1	49	20	and	and	CC
cord-279485-hajrnur1	49	21	3	3	CD
cord-279485-hajrnur1	49	22	went	go	VBD
cord-279485-hajrnur1	49	23	to	to	IN
cord-279485-hajrnur1	49	24	the	the	DT
cord-279485-hajrnur1	49	25	intensive	intensive	JJ
cord-279485-hajrnur1	49	26	care	care	NN
cord-279485-hajrnur1	49	27	unit	unit	NN
cord-279485-hajrnur1	49	28	and	and	CC
cord-279485-hajrnur1	49	29	one	one	NN
cord-279485-hajrnur1	49	30	did	do	VBD
cord-279485-hajrnur1	49	31	not	not	RB
cord-279485-hajrnur1	49	32	tolerate	tolerate	VB
cord-279485-hajrnur1	49	33	the	the	DT
cord-279485-hajrnur1	49	34	treatment	treatment	NN
cord-279485-hajrnur1	49	35	.	.	.
cord-279485-hajrnur1	50	1	The	the	DT
cord-279485-hajrnur1	50	2	controls	control	NNS
cord-279485-hajrnur1	50	3	were	be	VBD
cord-279485-hajrnur1	50	4	from	from	IN
cord-279485-hajrnur1	50	5	a	a	DT
cord-279485-hajrnur1	50	6	different	different	JJ
cord-279485-hajrnur1	50	7	hospital	hospital	NN
cord-279485-hajrnur1	50	8	;	;	:
cord-279485-hajrnur1	50	9	so	so	RB
cord-279485-hajrnur1	50	10	,	,	,
cord-279485-hajrnur1	50	11	it	-PRON-	PRP
cord-279485-hajrnur1	50	12	is	be	VBZ
cord-279485-hajrnur1	50	13	difficult	difficult	JJ
cord-279485-hajrnur1	50	14	to	to	TO
cord-279485-hajrnur1	50	15	interpret	interpret	VB
cord-279485-hajrnur1	50	16	the	the	DT
cord-279485-hajrnur1	50	17	data	datum	NNS
cord-279485-hajrnur1	50	18	meaningfully	meaningfully	RB
cord-279485-hajrnur1	50	19	in	in	IN
cord-279485-hajrnur1	50	20	my	-PRON-	PRP$
cord-279485-hajrnur1	50	21	opinion	opinion	NN
cord-279485-hajrnur1	50	22	.	.	.
cord-279485-hajrnur1	51	1	This	this	DT
cord-279485-hajrnur1	51	2	resulted	result	VBD
cord-279485-hajrnur1	51	3	in	in	IN
cord-279485-hajrnur1	51	4	a	a	DT
cord-279485-hajrnur1	51	5	shortage	shortage	NN
cord-279485-hajrnur1	51	6	of	of	IN
cord-279485-hajrnur1	51	7	medication	medication	NN
cord-279485-hajrnur1	51	8	.	.	.
cord-279485-hajrnur1	52	1	For	for	IN
cord-279485-hajrnur1	52	2	instance	instance	NN
cord-279485-hajrnur1	52	3	,	,	,
cord-279485-hajrnur1	52	4	in	in	IN
cord-279485-hajrnur1	52	5	Canada	Canada	NNP
cord-279485-hajrnur1	52	6	monthly	monthly	RB
cord-279485-hajrnur1	52	7	,	,	,
cord-279485-hajrnur1	52	8	there	there	EX
cord-279485-hajrnur1	52	9	are	be	VBP
cord-279485-hajrnur1	52	10	approximately	approximately	RB
cord-279485-hajrnur1	52	11	47,000	47,000	CD
cord-279485-hajrnur1	52	12	doses	dose	NNS
cord-279485-hajrnur1	52	13	of	of	IN
cord-279485-hajrnur1	52	14	hydroxychloroquine	hydroxychloroquine	NNP
cord-279485-hajrnur1	52	15	sold	sell	VBD
cord-279485-hajrnur1	52	16	monthly	monthly	JJ
cord-279485-hajrnur1	52	17	and	and	CC
cord-279485-hajrnur1	52	18	the	the	DT
cord-279485-hajrnur1	52	19	level	level	NN
cord-279485-hajrnur1	52	20	has	have	VBZ
cord-279485-hajrnur1	52	21	been	be	VBN
cord-279485-hajrnur1	52	22	constant	constant	JJ
cord-279485-hajrnur1	52	23	for	for	IN
cord-279485-hajrnur1	52	24	5	5	CD
cord-279485-hajrnur1	52	25	years	year	NNS
cord-279485-hajrnur1	52	26	,	,	,
cord-279485-hajrnur1	52	27	and	and	CC
cord-279485-hajrnur1	52	28	in	in	IN
cord-279485-hajrnur1	52	29	March	March	NNP
cord-279485-hajrnur1	52	30	,	,	,
cord-279485-hajrnur1	52	31	2020	2020	CD
cord-279485-hajrnur1	52	32	after	after	IN
cord-279485-hajrnur1	52	33	the	the	DT
cord-279485-hajrnur1	52	34	results	result	NNS
cord-279485-hajrnur1	52	35	of	of	IN
cord-279485-hajrnur1	52	36	the	the	DT
cord-279485-hajrnur1	52	37	small	small	JJ
cord-279485-hajrnur1	52	38	study	study	NN
cord-279485-hajrnur1	52	39	were	be	VBD
cord-279485-hajrnur1	52	40	announced	announce	VBN
cord-279485-hajrnur1	52	41	,	,	,
cord-279485-hajrnur1	52	42	the	the	DT
cord-279485-hajrnur1	52	43	sales	sale	NNS
cord-279485-hajrnur1	52	44	more	more	RBR
cord-279485-hajrnur1	52	45	than	than	IN
cord-279485-hajrnur1	52	46	doubled	double	VBD
cord-279485-hajrnur1	52	47	in	in	IN
cord-279485-hajrnur1	52	48	a	a	DT
cord-279485-hajrnur1	52	49	couple	couple	NN
cord-279485-hajrnur1	52	50	of	of	IN
cord-279485-hajrnur1	52	51	weeks	week	NNS
cord-279485-hajrnur1	52	52	causing	cause	VBG
cord-279485-hajrnur1	52	53	a	a	DT
cord-279485-hajrnur1	52	54	shortage	shortage	NN
cord-279485-hajrnur1	52	55	for	for	IN
cord-279485-hajrnur1	52	56	patients	patient	NNS
cord-279485-hajrnur1	52	57	and	and	CC
cord-279485-hajrnur1	52	58	high	high	JJ
cord-279485-hajrnur1	52	59	anxiety	anxiety	NN
cord-279485-hajrnur1	52	60	in	in	IN
cord-279485-hajrnur1	52	61	many	many	JJ
cord-279485-hajrnur1	52	62	of	of	IN
cord-279485-hajrnur1	52	63	them	-PRON-	PRP
cord-279485-hajrnur1	52	64	[	[	-LRB-
cord-279485-hajrnur1	52	65	12	12	CD
cord-279485-hajrnur1	52	66	]	]	-RRB-
cord-279485-hajrnur1	52	67	.	.	.
cord-279485-hajrnur1	53	1	This	this	DT
cord-279485-hajrnur1	53	2	is	be	VBZ
cord-279485-hajrnur1	53	3	being	be	VBG
cord-279485-hajrnur1	53	4	resolved	resolve	VBN
cord-279485-hajrnur1	53	5	in	in	IN
cord-279485-hajrnur1	53	6	many	many	JJ
cord-279485-hajrnur1	53	7	countries	country	NNS
cord-279485-hajrnur1	53	8	with	with	IN
cord-279485-hajrnur1	53	9	more	more	JJR
cord-279485-hajrnur1	53	10	suppliers	supplier	NNS
cord-279485-hajrnur1	53	11	producing	produce	VBG
cord-279485-hajrnur1	53	12	hydroxychloroquine	hydroxychloroquine	NN
cord-279485-hajrnur1	53	13	.	.	.
cord-279485-hajrnur1	54	1	This	this	DT
cord-279485-hajrnur1	54	2	has	have	VBZ
cord-279485-hajrnur1	54	3	led	lead	VBN
cord-279485-hajrnur1	54	4	to	to	IN
cord-279485-hajrnur1	54	5	statements	statement	NNS
cord-279485-hajrnur1	54	6	from	from	IN
cord-279485-hajrnur1	54	7	Rheumatology	Rheumatology	NNP
cord-279485-hajrnur1	54	8	organizations	organization	NNS
cord-279485-hajrnur1	54	9	to	to	TO
cord-279485-hajrnur1	54	10	ensure	ensure	VB
cord-279485-hajrnur1	54	11	a	a	DT
cord-279485-hajrnur1	54	12	constant	constant	JJ
cord-279485-hajrnur1	54	13	supply	supply	NN
cord-279485-hajrnur1	54	14	to	to	IN
cord-279485-hajrnur1	54	15	patients	patient	NNS
cord-279485-hajrnur1	54	16	with	with	IN
cord-279485-hajrnur1	54	17	rheumatic	rheumatic	JJ
cord-279485-hajrnur1	54	18	diseases	disease	NNS
cord-279485-hajrnur1	54	19	[	[	-LRB-
cord-279485-hajrnur1	54	20	13	13	CD
cord-279485-hajrnur1	54	21	]	]	-RRB-
cord-279485-hajrnur1	54	22	and	and	CC
cord-279485-hajrnur1	54	23	a	a	DT
cord-279485-hajrnur1	54	24	need	need	NN
cord-279485-hajrnur1	54	25	for	for	IN
cord-279485-hajrnur1	54	26	evidence	evidence	NN
cord-279485-hajrnur1	54	27	-	-	HYPH
cord-279485-hajrnur1	54	28	based	base	VBN
cord-279485-hajrnur1	54	29	treatment	treatment	NN
cord-279485-hajrnur1	54	30	[	[	-LRB-
cord-279485-hajrnur1	54	31	14	14	CD
cord-279485-hajrnur1	54	32	]	]	-RRB-
cord-279485-hajrnur1	54	33	.	.	.
cord-279485-hajrnur1	55	1	Despite	despite	IN
cord-279485-hajrnur1	55	2	a	a	DT
cord-279485-hajrnur1	55	3	lack	lack	NN
cord-279485-hajrnur1	55	4	of	of	IN
cord-279485-hajrnur1	55	5	strong	strong	JJ
cord-279485-hajrnur1	55	6	data	datum	NNS
cord-279485-hajrnur1	55	7	supporting	support	VBG
cord-279485-hajrnur1	55	8	antimalarial	antimalarial	JJ
cord-279485-hajrnur1	55	9	use	use	NN
cord-279485-hajrnur1	55	10	,	,	,
cord-279485-hajrnur1	55	11	the	the	DT
cord-279485-hajrnur1	55	12	WHO	who	WP
cord-279485-hajrnur1	55	13	has	have	VBZ
cord-279485-hajrnur1	55	14	facilitated	facilitate	VBN
cord-279485-hajrnur1	55	15	a	a	DT
cord-279485-hajrnur1	55	16	multi	multi	JJ
cord-279485-hajrnur1	55	17	-	-	JJ
cord-279485-hajrnur1	55	18	arm	arm	JJ
cord-279485-hajrnur1	55	19	trial	trial	NN
cord-279485-hajrnur1	55	20	(	(	-LRB-
cord-279485-hajrnur1	55	21	SOLIDARITY	SOLIDARITY	NNP
cord-279485-hajrnur1	55	22	)	)	-RRB-
cord-279485-hajrnur1	55	23	[	[	-LRB-
cord-279485-hajrnur1	55	24	15	15	CD
cord-279485-hajrnur1	55	25	]	]	-RRB-
cord-279485-hajrnur1	55	26	where	where	WRB
cord-279485-hajrnur1	55	27	standard	standard	NN
cord-279485-hajrnur1	55	28	of	of	IN
cord-279485-hajrnur1	55	29	care	care	NN
cord-279485-hajrnur1	55	30	will	will	MD
cord-279485-hajrnur1	55	31	be	be	VB
cord-279485-hajrnur1	55	32	compared	compare	VBN
cord-279485-hajrnur1	55	33	to	to	IN
cord-279485-hajrnur1	55	34	several	several	JJ
cord-279485-hajrnur1	55	35	other	other	JJ
cord-279485-hajrnur1	55	36	treatment	treatment	NN
cord-279485-hajrnur1	55	37	arms	arm	NNS
cord-279485-hajrnur1	55	38	including	include	VBG
cord-279485-hajrnur1	55	39	those	those	DT
cord-279485-hajrnur1	55	40	randomized	randomize	VBN
cord-279485-hajrnur1	55	41	to	to	IN
cord-279485-hajrnur1	55	42	hydroxy	hydroxy	NN
cord-279485-hajrnur1	55	43	/	/	SYM
cord-279485-hajrnur1	55	44	chloroquine	chloroquine	NN
cord-279485-hajrnur1	55	45	,	,	,
cord-279485-hajrnur1	55	46	or	or	CC
cord-279485-hajrnur1	55	47	HIV	HIV	NNP
cord-279485-hajrnur1	55	48	antivirals	antiviral	NNS
cord-279485-hajrnur1	55	49	(	(	-LRB-
cord-279485-hajrnur1	55	50	ritonavir	ritonavir	NNP
cord-279485-hajrnur1	55	51	+	+	SYM
cord-279485-hajrnur1	55	52	iopinavir	iopinavir	NNP
cord-279485-hajrnur1	55	53	)	)	-RRB-
cord-279485-hajrnur1	55	54	or	or	CC
cord-279485-hajrnur1	55	55	ritonavir	ritonavir	NNP
cord-279485-hajrnur1	55	56	+	+	SYM
cord-279485-hajrnur1	55	57	iopinavir	iopinavir	NNS
cord-279485-hajrnur1	56	1	+	+	CC
cord-279485-hajrnur1	57	1	interferon	interferon	NN
cord-279485-hajrnur1	57	2	beta	beta	NN
cord-279485-hajrnur1	57	3	,	,	,
cord-279485-hajrnur1	57	4	or	or	CC
cord-279485-hajrnur1	57	5	an	an	DT
cord-279485-hajrnur1	57	6	antiviral	antiviral	JJ
cord-279485-hajrnur1	57	7	used	use	VBN
cord-279485-hajrnur1	57	8	for	for	IN
cord-279485-hajrnur1	57	9	Ebola	Ebola	NNP
cord-279485-hajrnur1	57	10	(	(	-LRB-
cord-279485-hajrnur1	57	11	remdesivir	remdesivir	NNP
cord-279485-hajrnur1	57	12	)	)	-RRB-
cord-279485-hajrnur1	57	13	.	.	.
cord-279485-hajrnur1	58	1	Not	not	RB
cord-279485-hajrnur1	58	2	all	all	DT
cord-279485-hajrnur1	58	3	countries	country	NNS
cord-279485-hajrnur1	58	4	will	will	MD
cord-279485-hajrnur1	58	5	have	have	VB
cord-279485-hajrnur1	58	6	all	all	DT
cord-279485-hajrnur1	58	7	comparators	comparator	NNS
cord-279485-hajrnur1	58	8	[	[	-LRB-
cord-279485-hajrnur1	58	9	16	16	CD
cord-279485-hajrnur1	58	10	]	]	-RRB-
cord-279485-hajrnur1	58	11	.	.	.
cord-279485-hajrnur1	59	1	After	after	IN
cord-279485-hajrnur1	59	2	the	the	DT
cord-279485-hajrnur1	59	3	pandemic	pandemic	NN
cord-279485-hajrnur1	59	4	is	be	VBZ
cord-279485-hajrnur1	59	5	over	over	RB
cord-279485-hajrnur1	59	6	,	,	,
cord-279485-hajrnur1	59	7	the	the	DT
cord-279485-hajrnur1	59	8	world	world	NN
cord-279485-hajrnur1	59	9	economy	economy	NN
cord-279485-hajrnur1	59	10	will	will	MD
cord-279485-hajrnur1	59	11	be	be	VB
cord-279485-hajrnur1	59	12	harmed	harm	VBN
cord-279485-hajrnur1	59	13	and	and	CC
cord-279485-hajrnur1	59	14	patients	patient	NNS
cord-279485-hajrnur1	59	15	will	will	MD
cord-279485-hajrnur1	59	16	have	have	VB
cord-279485-hajrnur1	59	17	suffered	suffer	VBN
cord-279485-hajrnur1	59	18	from	from	IN
cord-279485-hajrnur1	59	19	stress	stress	NN
cord-279485-hajrnur1	59	20	,	,	,
cord-279485-hajrnur1	59	21	income	income	NN
cord-279485-hajrnur1	59	22	,	,	,
cord-279485-hajrnur1	59	23	or	or	CC
cord-279485-hajrnur1	59	24	job	job	NN
cord-279485-hajrnur1	59	25	loss	loss	NN
cord-279485-hajrnur1	59	26	and	and	CC
cord-279485-hajrnur1	59	27	possibly	possibly	RB
cord-279485-hajrnur1	59	28	lack	lack	NN
cord-279485-hajrnur1	59	29	of	of	IN
cord-279485-hajrnur1	59	30	access	access	NN
cord-279485-hajrnur1	59	31	to	to	IN
cord-279485-hajrnur1	59	32	their	-PRON-	PRP$
cord-279485-hajrnur1	59	33	care	care	NN
cord-279485-hajrnur1	59	34	for	for	IN
cord-279485-hajrnur1	59	35	their	-PRON-	PRP$
cord-279485-hajrnur1	59	36	chronic	chronic	JJ
cord-279485-hajrnur1	59	37	diseases	disease	NNS
cord-279485-hajrnur1	59	38	and	and	CC
cord-279485-hajrnur1	59	39	the	the	DT
cord-279485-hajrnur1	59	40	uncertainties	uncertainty	NNS
cord-279485-hajrnur1	59	41	of	of	IN
cord-279485-hajrnur1	59	42	medication	medication	NN
cord-279485-hajrnur1	59	43	supply	supply	NN
cord-279485-hajrnur1	59	44	.	.	.
cord-279485-hajrnur1	60	1	Many	many	JJ
cord-279485-hajrnur1	60	2	people	people	NNS
cord-279485-hajrnur1	60	3	will	will	MD
cord-279485-hajrnur1	60	4	die	die	VB
cord-279485-hajrnur1	60	5	due	due	IN
cord-279485-hajrnur1	60	6	to	to	IN
cord-279485-hajrnur1	60	7	the	the	DT
cord-279485-hajrnur1	60	8	pandemic	pandemic	NN
cord-279485-hajrnur1	60	9	and	and	CC
cord-279485-hajrnur1	60	10	others	other	NNS
cord-279485-hajrnur1	60	11	may	may	MD
cord-279485-hajrnur1	60	12	have	have	VB
cord-279485-hajrnur1	60	13	worse	bad	JJR
cord-279485-hajrnur1	60	14	outcomes	outcome	NNS
cord-279485-hajrnur1	60	15	from	from	IN
cord-279485-hajrnur1	60	16	their	-PRON-	PRP$
cord-279485-hajrnur1	60	17	chronic	chronic	JJ
cord-279485-hajrnur1	60	18	disease	disease	NN
cord-279485-hajrnur1	60	19	as	as	IN
cord-279485-hajrnur1	60	20	they	-PRON-	PRP
cord-279485-hajrnur1	60	21	may	may	MD
cord-279485-hajrnur1	60	22	not	not	RB
cord-279485-hajrnur1	60	23	have	have	VB
cord-279485-hajrnur1	60	24	access	access	NN
cord-279485-hajrnur1	60	25	to	to	IN
cord-279485-hajrnur1	60	26	their	-PRON-	PRP$
cord-279485-hajrnur1	60	27	physicians	physician	NNS
cord-279485-hajrnur1	60	28	due	due	JJ
cord-279485-hajrnur1	60	29	to	to	IN
cord-279485-hajrnur1	60	30	quarantines	quarantine	NNS
cord-279485-hajrnur1	60	31	and	and	CC
cord-279485-hajrnur1	60	32	diversion	diversion	NN
cord-279485-hajrnur1	60	33	of	of	IN
cord-279485-hajrnur1	60	34	hospital	hospital	NN
cord-279485-hajrnur1	60	35	resources	resource	NNS
cord-279485-hajrnur1	60	36	to	to	TO
cord-279485-hajrnur1	60	37	treat	treat	VB
cord-279485-hajrnur1	60	38	the	the	DT
cord-279485-hajrnur1	60	39	seriously	seriously	RB
cord-279485-hajrnur1	60	40	ill	ill	JJ
cord-279485-hajrnur1	60	41	infected	infect	VBN
cord-279485-hajrnur1	60	42	from	from	IN
cord-279485-hajrnur1	60	43	COVID-19	COVID-19	NNP
cord-279485-hajrnur1	60	44	.	.	.
cord-279485-hajrnur1	61	1	Hopefully	hopefully	RB
cord-279485-hajrnur1	61	2	,	,	,
cord-279485-hajrnur1	61	3	lessons	lesson	NNS
cord-279485-hajrnur1	61	4	will	will	MD
cord-279485-hajrnur1	61	5	quickly	quickly	RB
cord-279485-hajrnur1	61	6	be	be	VB
cord-279485-hajrnur1	61	7	learned	learn	VBN
cord-279485-hajrnur1	61	8	about	about	IN
cord-279485-hajrnur1	61	9	stopping	stop	VBG
cord-279485-hajrnur1	61	10	the	the	DT
cord-279485-hajrnur1	61	11	spread	spread	NN
cord-279485-hajrnur1	61	12	,	,	,
cord-279485-hajrnur1	61	13	communicating	communicate	VBG
cord-279485-hajrnur1	61	14	clear	clear	JJ
cord-279485-hajrnur1	61	15	messages	message	NNS
cord-279485-hajrnur1	61	16	to	to	IN
cord-279485-hajrnur1	61	17	our	-PRON-	PRP$
cord-279485-hajrnur1	61	18	patients	patient	NNS
cord-279485-hajrnur1	61	19	and	and	CC
cord-279485-hajrnur1	61	20	providing	provide	VBG
cord-279485-hajrnur1	61	21	high	high	JJ
cord-279485-hajrnur1	61	22	-	-	HYPH
cord-279485-hajrnur1	61	23	quality	quality	NN
cord-279485-hajrnur1	61	24	health	health	NN
cord-279485-hajrnur1	61	25	care	care	NN
cord-279485-hajrnur1	61	26	to	to	IN
cord-279485-hajrnur1	61	27	those	those	DT
cord-279485-hajrnur1	61	28	who	who	WP
cord-279485-hajrnur1	61	29	need	need	VBP
cord-279485-hajrnur1	61	30	it	-PRON-	PRP
cord-279485-hajrnur1	61	31	.	.	.
cord-279485-hajrnur1	62	1	There	there	EX
cord-279485-hajrnur1	62	2	was	be	VBD
cord-279485-hajrnur1	62	3	no	no	DT
cord-279485-hajrnur1	62	4	financial	financial	JJ
cord-279485-hajrnur1	62	5	support	support	NN
cord-279485-hajrnur1	62	6	for	for	IN
cord-279485-hajrnur1	62	7	this	this	DT
cord-279485-hajrnur1	62	8	project	project	NN
cord-279485-hajrnur1	62	9	.	.	.
cord-279485-hajrnur1	63	1	The	the	DT
cord-279485-hajrnur1	63	2	author	author	NN
cord-279485-hajrnur1	63	3	declares	declare	VBZ
cord-279485-hajrnur1	63	4	that	that	IN
cord-279485-hajrnur1	63	5	she	-PRON-	PRP
cord-279485-hajrnur1	63	6	has	have	VBZ
cord-279485-hajrnur1	63	7	no	no	DT
cord-279485-hajrnur1	63	8	conflict	conflict	NN
cord-279485-hajrnur1	63	9	of	of	IN
cord-279485-hajrnur1	63	10	interest	interest	NN
cord-279485-hajrnur1	63	11	.	.	.
cord-279485-hajrnur1	64	1	This	this	DT
cord-279485-hajrnur1	64	2	article	article	NN
cord-279485-hajrnur1	64	3	does	do	VBZ
cord-279485-hajrnur1	64	4	not	not	RB
cord-279485-hajrnur1	64	5	contain	contain	VB
cord-279485-hajrnur1	64	6	any	any	DT
cord-279485-hajrnur1	64	7	studies	study	NNS
cord-279485-hajrnur1	64	8	with	with	IN
cord-279485-hajrnur1	64	9	human	human	JJ
cord-279485-hajrnur1	64	10	or	or	CC
cord-279485-hajrnur1	64	11	animal	animal	NN
cord-279485-hajrnur1	64	12	subjects	subject	NNS
cord-279485-hajrnur1	64	13	performed	perform	VBN
cord-279485-hajrnur1	64	14	by	by	IN
cord-279485-hajrnur1	64	15	any	any	DT
cord-279485-hajrnur1	64	16	of	of	IN
cord-279485-hajrnur1	64	17	the	the	DT
cord-279485-hajrnur1	64	18	authors	author	NNS
cord-279485-hajrnur1	64	19	.	.	.
cord-279485-hajrnur1	65	1	There	there	EX
cord-279485-hajrnur1	65	2	was	be	VBD
cord-279485-hajrnur1	65	3	no	no	DT
cord-279485-hajrnur1	65	4	institutional	institutional	JJ
cord-279485-hajrnur1	65	5	ethics	ethic	NNS
cord-279485-hajrnur1	65	6	approval	approval	NN
cord-279485-hajrnur1	65	7	as	as	IN
cord-279485-hajrnur1	65	8	this	this	DT
cord-279485-hajrnur1	65	9	is	be	VBZ
cord-279485-hajrnur1	65	10	a	a	DT
cord-279485-hajrnur1	65	11	commentary	commentary	NN
cord-279485-hajrnur1	65	12	.	.	.
cord-279485-hajrnur1	66	1	What	what	WP
cord-279485-hajrnur1	66	2	Does	do	VBZ
cord-279485-hajrnur1	66	3	the	the	DT
cord-279485-hajrnur1	66	4	COVID-19	COVID-19	NNP
cord-279485-hajrnur1	66	5	Pandemic	Pandemic	NNP
cord-279485-hajrnur1	66	6	Mean	Mean	NNP
cord-279485-hajrnur1	66	7	for	for	IN
cord-279485-hajrnur1	66	8	Rheumatology	Rheumatology	NNP
cord-279485-hajrnur1	66	9	Patients	patient	NNS
cord-279485-hajrnur1	66	10	?	?	.
cord-279485-hajrnur1	67	1	Pope	Pope	NNP
cord-279485-hajrnur1	67	2	Consensus	Consensus	NNP
cord-279485-hajrnur1	67	3	document	document	NN
cord-279485-hajrnur1	67	4	on	on	IN
cord-279485-hajrnur1	67	5	the	the	DT
cord-279485-hajrnur1	67	6	epidemiology	epidemiology	NN
cord-279485-hajrnur1	67	7	of	of	IN
cord-279485-hajrnur1	67	8	severe	severe	JJ
cord-279485-hajrnur1	67	9	acute	acute	JJ
cord-279485-hajrnur1	67	10	respiratory	respiratory	JJ
cord-279485-hajrnur1	67	11	syndrome	syndrome	NN
cord-279485-hajrnur1	67	12	(	(	-LRB-
cord-279485-hajrnur1	67	13	SARS	SARS	NNP
cord-279485-hajrnur1	67	14	)	)	-RRB-
cord-279485-hajrnur1	68	1	Clinical	clinical	JJ
cord-279485-hajrnur1	68	2	course	course	NN
cord-279485-hajrnur1	68	3	and	and	CC
cord-279485-hajrnur1	68	4	risk	risk	NN
cord-279485-hajrnur1	68	5	factors	factor	NNS
cord-279485-hajrnur1	68	6	for	for	IN
cord-279485-hajrnur1	68	7	mortality	mortality	NN
cord-279485-hajrnur1	68	8	of	of	IN
cord-279485-hajrnur1	68	9	adult	adult	NN
cord-279485-hajrnur1	68	10	inpatients	inpatient	NNS
cord-279485-hajrnur1	68	11	with	with	IN
cord-279485-hajrnur1	68	12	COVID-19	COVID-19	NNP
cord-279485-hajrnur1	68	13	in	in	IN
cord-279485-hajrnur1	68	14	Wuhan	Wuhan	NNP
cord-279485-hajrnur1	68	15	,	,	,
cord-279485-hajrnur1	68	16	China	China	NNP
cord-279485-hajrnur1	68	17	:	:	:
cord-279485-hajrnur1	68	18	a	a	DT
cord-279485-hajrnur1	68	19	retrospective	retrospective	JJ
cord-279485-hajrnur1	68	20	cohort	cohort	NN
cord-279485-hajrnur1	68	21	study	study	NN
cord-279485-hajrnur1	68	22	Clinical	Clinical	NNP
cord-279485-hajrnur1	68	23	course	course	NN
cord-279485-hajrnur1	68	24	of	of	IN
cord-279485-hajrnur1	68	25	COVID-19	COVID-19	NNP
cord-279485-hajrnur1	68	26	in	in	IN
cord-279485-hajrnur1	68	27	a	a	DT
cord-279485-hajrnur1	68	28	series	series	NN
cord-279485-hajrnur1	68	29	of	of	IN
cord-279485-hajrnur1	68	30	patients	patient	NNS
cord-279485-hajrnur1	68	31	with	with	IN
cord-279485-hajrnur1	68	32	chronic	chronic	JJ
cord-279485-hajrnur1	68	33	arthritis	arthritis	NN
cord-279485-hajrnur1	68	34	treated	treat	VBN
cord-279485-hajrnur1	68	35	with	with	IN
cord-279485-hajrnur1	68	36	immunosuppressive	immunosuppressive	JJ
cord-279485-hajrnur1	68	37	targeted	target	VBN
cord-279485-hajrnur1	68	38	therapies	therapy	NNS
cord-279485-hajrnur1	68	39	?	?	.
cord-279485-hajrnur1	69	1	term=	term=	NNP
cord-279485-hajrnur1	70	1	Plaquenil&ingredient=&atc_code=&atc	Plaquenil&ingredient=&atc_code=&atc	NNP
cord-279485-hajrnur1	71	1	_	_	NNP
cord-279485-hajrnur1	71	2	descriptor=&_token=	descriptor=&_token=	NNP
cord-279485-hajrnur1	71	3	IC7secHlJyidQn5XlSRrpqjSE5wRYEZpspfjQ8CZ	IC7secHlJyidQn5XlSRrpqjSE5wRYEZpspfjQ8CZ	NNP
cord-279485-hajrnur1	71	4	-	-	HYPH
cord-279485-hajrnur1	71	5	C0	c0	NN
cord-279485-hajrnur1	71	6	referenced	reference	VBN
cord-279485-hajrnur1	71	7	on	on	IN
cord-279485-hajrnur1	71	8	April	April	NNP
cord-279485-hajrnur1	71	9	6	6	CD
cord-279485-hajrnur1	71	10	,	,	,
cord-279485-hajrnur1	71	11	2020	2020	CD
cord-279485-hajrnur1	71	12	.	.	.
cord-279485-hajrnur1	71	13	13	13	CD